SourceOne Healthcare Technologies and CompuMed Announce Strategic Distribution Agreement
SourceOne will market and distribute CompuMed’s innovative DICOM OsteoGram® software that may be added to existing computed radiography (CR) and digital radiography (DR) systems enabling them to perform bone mineral density screening. This new capability will be introduced at the 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago (November 29-December 3)at the SourceOne exhibit (McCormick Place South Building, booth # 1919).
Mentor, OH; Los Angeles, CA (PRWEB) November 18, 2004
SourceOne Healthcare Technologies, Inc., the nationÂ’s leading distributor of medical imaging systems, equipment, radiographic consumable supplies, and service to healthcare providers, and CompuMed, Inc., (OTC BB: CMPD. OB), a leading developer of computer-aided telemedicine and diagnostics technology in the cardiology and musculoskeletal fields, today announced the companies have signed a new nationwide distribution agreement.
Under the terms of the agreement, SourceOne will market and distribute CompuMed’s innovative DICOM OsteoGram® software that may be added to existing computed radiography (CR) and digital radiography (DR) systems enabling them to perform bone mineral density screening for early detection and treatment of osteoporosis. This new capability will be introduced at the 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago (November 29-December 3). The DICOM OsteoGram® will be on display at the SourceOne exhibit (McCormick Place South Building, booth # 1919).
This breakthrough second-generation technology will give SourceOne’s customers the ability to use a simple hand x-ray to precisely determine bone mineral density (BMD) as an indicator of osteoporosis and future fracture risk. The hand x-ray film is scanned at the healthcare provider’s office with a standard desktop scanner, and the Automated OsteoGram® software analysis program instantly produces a BMD report comparable to tests performed on the expensive, dedicated BMD testing equipment generally found in hospitals and specialty practices.
By enabling physicians everywhere to detect bone loss before fractures actually occur, and intervene early in the disease stage with available effective treatments, the Automated OsteoGram can play a major role in reducing the incidence of osteoporosis, one of the worldÂ’s most prevalent and yet preventable diseases.
“One out of every two women over the age of 50 will experience an osteoporosis-related fracture in her lifetime,” said Jerry McLaughlin, CompuMed president and CEO. “Yet many women do not realize that they are at risk for osteoporosis until they suffer a fracture. Recognizing SourceOne’s excellent national distribution capabilities, and because the company is truly dedicated to help improving women’s health, we are excited about the opportunity to provide cutting-edge women’s health imaging solutions with a new partner that understands our technology and complements our organization.”
McLaughlin added, “With an investment that quickly pays for itself, the DICOM OsteoGram® unique add-on solution, transforms an existing CR or DR system into a bone density measurement system. This is a perfect fit for SourceOne’s large customer base of women’s imaging centers, orthopedic offices and hundreds of CR installations.”
“We are committed to improving women’s health,” said Jerry C. Cirino, SourceOne president and CEO. “CompuMed’s DICOM OsteoGram® DICOM enables our customers to provide convenient in-office osteoporosis testing whereby the patient can be easily and quickly tested anywhere that there is an installed CR or DR unit. Our national sales and service capabilities, coupled with a dedicated team of women’s health sales specialists, will enable us to bring the benefits of CompuMed’s technology to aid in the early detection and treatment of osteoporosis.”
About SourceOne Healthcare Technologies
Headquartered in Mentor, Ohio, SourceOne Healthcare Technologies is a leading provider of imaging equipment and radiographic supplies and services tailored to healthcare facilities, including those transitioning to a digital imaging environment. SourceOne offers broad lines of equipment and consumables as well as e-logistics, sales professionals and field-service engineers. Our wide offering enables customers to turn to SourceOne as the best in class source for effective supply chain and medical imaging management. SourceOne is a privately held company of Platinum Equity, a global acquisitions firm specializing in the strategic operation of mission-critical companies. Visit SourceOne at http://www. sourceonehealth. com (http://www. sourceonehealth. com).
About CompuMed
Founded in 1973, CompuMed, Inc. (CMPD. OB) is a leading provider of computer-aided telemedicine and diagnostics technology. The company's core products are the OsteoGram® and CardioGram® systems. The OsteoGram®, which is cleared by the FDA for commercial use, is an accurate and precise technology for low-cost osteoporosis testing. The CardioGram® system remotely interprets electrocardiograms and is used by private practice, government and corporate healthcare providers nationwide. The CardioGram® has the additional capability to automatically provide an over-read (i. e., follow-up review) by a cardiologist. CompuMed is headquartered in Los Angeles. Visit CompuMed at www. compumed. net. OsteoGram® is a registered trademark of CompuMed, Inc.
CompuMed Safe Harbor Forward-Looking Statements
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, ability to raise capital, availability of appropriate acquisition candidates and/or business partnerships, economic conditions, impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks defined in this document. All such forward-looking statements whether written or oral, and whether made by or on behalf of the Companies are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
# # #
.jpg)
